CY1111453T1 - Υγρο που περιλαμβανει τρεαλοζη για χρηση στην προληψη συμφυσης ιστου - Google Patents

Υγρο που περιλαμβανει τρεαλοζη για χρηση στην προληψη συμφυσης ιστου

Info

Publication number
CY1111453T1
CY1111453T1 CY20111100275T CY111100275T CY1111453T1 CY 1111453 T1 CY1111453 T1 CY 1111453T1 CY 20111100275 T CY20111100275 T CY 20111100275T CY 111100275 T CY111100275 T CY 111100275T CY 1111453 T1 CY1111453 T1 CY 1111453T1
Authority
CY
Cyprus
Prior art keywords
solution
fluid
tissue
trailoze
liquid includes
Prior art date
Application number
CY20111100275T
Other languages
English (en)
Inventor
Shigeki Suzuki
Yoshikatsu Miwa
Nobuo Sasaki
Yuichi Tei
Original Assignee
Otsuka Pharmaceutical Factory, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Factory, Inc. filed Critical Otsuka Pharmaceutical Factory, Inc.
Publication of CY1111453T1 publication Critical patent/CY1111453T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Το αντικείμενο της εφεύρεσης είναι να παρέχει διάλυμα για πρόληψη σύμφυσης ιστού και μέθοδο για πρόληψη σύμφυσης ιστού που μπορεί να εφαρμοστεί σε γενικό χειρουργείο και στην οποία η κατάσταση κάλυψης κατά τη διάρκεια του χειρουργείου είναι σταθερή και εύκολη. Η εφεύρεση είναι το διάλυμα για πρόληψη σύνθεσης ιστού του οποίου το δραστικό συστατικό είναι η τρεαλόζη. Επίσης, περιέχει τουλάχιστον ένα ή περισσότερα αντιοξειδωτικά, χηλικά, αντισηπτικά, αιμοστατικά, αντιφλεγμονώδεις παράγοντες και πολυσακχαρίτες, βλεννοπολυσακχαρίτες, άλατα πολυσακχαριτών και άλατα βλεννοπολυσακχαριτών που έχουν λιπαντικές ιδιότητες. Αυτό το διάλυμα για πρόληψη σύνθεσης ιστού παρέχεται σε οποιαδήποτε μορφή ρευστού διαποτισμού, ρευστού ψεκασμού, διαλύματος για χορήγηση με ψεκασμό ή εξάτμιση, παρασκευάσματος αεροδιαλύματος που μοιάζει με αφρό, διαλύματος έγχυσης για ενδοφλέβια ρευστά, ενδοφλέβιου ρευστού.
CY20111100275T 2005-06-08 2011-03-11 Υγρο που περιλαμβανει τρεαλοζη για χρηση στην προληψη συμφυσης ιστου CY1111453T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005168744 2005-06-08
EP20060766477 EP1905443B1 (en) 2005-06-08 2006-06-08 Liquid comprising trehalose for use in preventing tissue adhesion

Publications (1)

Publication Number Publication Date
CY1111453T1 true CY1111453T1 (el) 2015-08-05

Family

ID=37498506

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100275T CY1111453T1 (el) 2005-06-08 2011-03-11 Υγρο που περιλαμβανει τρεαλοζη για χρηση στην προληψη συμφυσης ιστου

Country Status (23)

Country Link
US (2) US20090098061A1 (el)
EP (1) EP1905443B1 (el)
JP (1) JP4447640B2 (el)
KR (1) KR101004551B1 (el)
CN (1) CN101193645B (el)
AU (1) AU2006256084B2 (el)
BR (1) BRPI0610889A8 (el)
CA (1) CA2611441C (el)
CY (1) CY1111453T1 (el)
DE (1) DE602006018936D1 (el)
DK (1) DK1905443T3 (el)
ES (1) ES2363674T3 (el)
HK (1) HK1113746A1 (el)
HR (1) HRP20110150T1 (el)
MY (1) MY142987A (el)
NO (1) NO20080106L (el)
NZ (1) NZ564399A (el)
PL (1) PL1905443T3 (el)
PT (1) PT1905443E (el)
RU (1) RU2395287C2 (el)
SI (1) SI1905443T1 (el)
TW (1) TWI340645B (el)
WO (1) WO2006132310A1 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention
JP5781727B2 (ja) * 2007-02-23 2015-09-24 株式会社ネクスト２１ 血管攣縮の治療剤又は予防剤
JP5340823B2 (ja) * 2008-06-24 2013-11-13 ナガセ医薬品株式会社 医療用潤滑剤
KR101062068B1 (ko) * 2008-12-01 2011-09-02 포항공과대학교 산학협력단 유착방지용 조성물
US9119897B2 (en) 2009-05-28 2015-09-01 Profibrix B.V. Dry powder fibrin sealant
GB0909136D0 (en) 2009-05-28 2009-07-01 Profibrix Bv Dry powder composition
JP5685751B2 (ja) * 2009-08-04 2015-03-18 国立大学法人弘前大学 結膜下線維芽細胞増殖抑制剤および結膜下線維芽細胞増殖抑制方法
SG180307A1 (en) 2009-09-03 2012-06-28 Hayashibara Biochem Lab Powder containing anhydrous crystals of 2-o-a-d-glucosyl-l-ascorbic acid, manufacturing method therefor, and use thereof
EP2615099B1 (en) 2010-09-07 2015-04-29 Hayashibara Co., Ltd. Hydrous crystals of 2-o-d-glucosyl-l-ascorbic acid, particulate composition comprising the same, their preparation and uses
CN103502260B (zh) 2011-03-07 2016-08-17 株式会社林原 含有2-O-α-D-葡萄糖基-L-抗坏血酸无水结晶的粉末的制造方法
ES2882911T3 (es) 2011-04-27 2021-12-03 Biomup France Sas Composiciones hemostáticas
WO2013112381A2 (en) 2012-01-24 2013-08-01 Bvw Holding Ag New class of anti-adhesion hydrogels with healing aspects
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
AU2014264228A1 (en) 2013-05-07 2015-11-12 Bio Blast Pharma Ltd. Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
CN104027341B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 一种皮肤护理组合物及其制剂
CN104107189B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 皮肤护理组合物及其制剂
CN104013639B (zh) * 2014-06-20 2016-08-31 天津嘉氏堂科技有限公司 一种具有皮肤修护功能的组合物及其凝胶剂
CN104257682B (zh) * 2014-10-28 2016-04-27 天津嘉氏堂科技有限公司 一种创面修护组合物及制剂
CN104257687B (zh) * 2014-10-28 2017-02-15 天津嘉氏堂科技有限公司 用于治疗皮肤创伤的组合物及其糊剂
CN104382931B (zh) * 2014-10-28 2017-06-13 天津嘉氏堂科技有限公司 皮肤创面护理组合物
FR3036044B1 (fr) * 2015-05-13 2021-04-30 Cha Ling Dispositif de pulverisation de molecules non volatiles et/ou instables a la temperature, methode de pulverisation associee
CN105168211B (zh) * 2015-10-13 2016-11-16 重庆华森制药股份有限公司 一种奥美拉唑钠药物组合物
EP3375456B1 (en) * 2015-11-12 2023-05-03 Terumo Kabushiki Kaisha Sustained-release topically administered agent
WO2017149584A1 (ja) * 2016-02-29 2017-09-08 川澄化学工業株式会社 癒着防止材
EP3452127A1 (en) 2016-05-03 2019-03-13 Bvw Holding AG Multiphase gel
DK3496770T3 (da) 2016-08-12 2021-06-21 Biomup France Sas Hæmostatisk flydbart materiale
WO2019044765A1 (ja) * 2017-08-28 2019-03-07 川澄化学工業株式会社 癒着防止材
KR102039552B1 (ko) * 2017-10-23 2019-11-01 이재혁 상처 부위에 도포되는 발포성 밴드
KR102427018B1 (ko) * 2019-06-11 2022-07-29 재단법인 베스티안재단 피부치료제의 제조방법 및 이로부터 얻어지는 피부치료제
WO2024014443A1 (ja) * 2022-07-12 2024-01-18 株式会社大塚製薬工場 カプセル化膵島の保存用又は移植用液

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994277A (en) * 1989-10-31 1991-02-19 Pfizer Hospital Products Group, Inc. Use of xanthan gum for preventing adhesions
JP2948254B2 (ja) 1990-03-06 1999-09-13 ユニチカ株式会社 癒着防止材
WO1993015234A1 (en) * 1992-01-22 1993-08-05 Novo Nordisk A/S Activated factor xiii
JP3572085B2 (ja) 1992-07-10 2004-09-29 味の素ファルマ株式会社 栄養輸液剤
JP3253131B2 (ja) 1992-07-24 2002-02-04 洋巳 和田 移植臓器用溶液
JP3418423B2 (ja) 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物
JPH06319486A (ja) 1993-03-16 1994-11-22 Hayashibara Biochem Lab Inc エネルギー用糖源とその用途
JP3420851B2 (ja) 1994-12-06 2003-06-30 株式会社資生堂 癒着防止剤
JP4033510B2 (ja) 1995-12-27 2008-01-16 ロート製薬株式会社 トレハロースを含有する眼科用医薬組成物
JP2868206B2 (ja) * 1996-04-16 1999-03-10 株式会社オフテクス 消毒および／または防腐のための有害微生物防除用組成物
DE69625254T2 (de) * 1996-06-14 2003-04-17 Biostore New Zealand Ltd Zusammensetzungen und verfahren zum konservieren von lebenden geweben
US5827640A (en) * 1996-06-14 1998-10-27 Biostore New Zealand Limited Methods for the preservation of cells and tissues using trimethylamine oxide or betaine with raffinose or trehalose
AU725247B2 (en) 1996-06-14 2000-10-12 Biostore New Zealand Limited Compositions and methods for the preservation of living tissues
US6020367A (en) * 1997-12-02 2000-02-01 Avon Products, Inc. Supersaturated ascorbic acid solutions
US6162393A (en) * 1998-08-06 2000-12-19 Ndt, Inc. Contact lens and ophthalmic solutions
US6365338B1 (en) * 1999-04-27 2002-04-02 David A. Bull Organ preservative solution containing trehalose, anti-oxidant, cations and an energy source
KR20020010920A (ko) * 1999-06-02 2002-02-06 추후제출 각질세포 성장 인자-2 제제
JP2002024832A (ja) 2000-06-30 2002-01-25 Koboruto:Kk 指紋データの管理方法および装置
JP2002047189A (ja) 2000-07-26 2002-02-12 Seishi Yoneda 心停止液
US6653062B1 (en) * 2000-07-26 2003-11-25 Wisconsin Alumni Research Foundation Preservation and storage medium for biological materials
US20040047892A1 (en) * 2000-11-15 2004-03-11 Desrosiers Eric Andre Filler composition for soft tissue augmentation and reconstructive surgery
US20060134140A1 (en) * 2001-04-12 2006-06-22 Dana Lasko Compositions and methods for treating tumor spreading
JP4286480B2 (ja) * 2001-09-17 2009-07-01 株式会社メニコン 殺菌液
JP4474165B2 (ja) * 2002-02-20 2010-06-02 株式会社ネクスト２１ 噴射用薬剤の調製方法
AU2002355005B2 (en) * 2002-06-03 2006-04-13 Cac Corporation External preparations for treating dermatitis
JP2004224677A (ja) * 2003-01-20 2004-08-12 Masahiro Nagahama 抗線虫及び病害虫等による食害軽減効果と抗ウイルス効果とを有する肥料組成物
CN1761450B (zh) * 2003-02-13 2010-05-05 株式会社林原生物化学研究所 特征在于含有α,α-海藻糖的糖类衍生物的皮肤外用剂
JPWO2004076602A1 (ja) * 2003-02-27 2006-06-08 株式会社林原生物化学研究所 脂質膜を構成している脂質の分解抑制方法及びその用途
JP2006525006A (ja) * 2003-05-08 2006-11-09 セルアーティス アーベー 閉塞ストローガラス化方法を利用するヒト胚盤胞由来幹細胞の低温保存法
FR2855177B1 (fr) 2003-05-23 2005-07-08 Raymond Robert Composition contenant des acides nucleiques lyophilises en presence de collagene et de disaccharides
AU2004245079A1 (en) 2003-06-05 2004-12-16 Cargill, Incorporated Beverage additive mixture of trehalose and protein
JP4439517B2 (ja) 2004-05-13 2010-03-24 株式会社ネクスト２１ 経内視鏡手術に用いる止血と、癒着の防止装置
US7433759B2 (en) * 2004-07-22 2008-10-07 Applied Materials, Inc. Apparatus and methods for positioning wafers
US20060047005A1 (en) * 2004-08-26 2006-03-02 Salamone Joseph C Compositions containing N,N,N',N'-tetrakis(hydroxyalkyl)diamine-or N,N,N',N'-tetrakis(hydroxyalkoxy)diamine-based buffers
JP2006188672A (ja) * 2004-12-06 2006-07-20 Hayashibara Biochem Lab Inc ラジカル生成抑制剤
MY142987A (en) * 2005-06-08 2011-02-14 Hayashibara Biochem Lab Solution for tissue adhesion prevention and method for tissue adhesion prevention

Also Published As

Publication number Publication date
HRP20110150T1 (hr) 2011-04-30
ES2363674T3 (es) 2011-08-11
TWI340645B (en) 2011-04-21
EP1905443A1 (en) 2008-04-02
DK1905443T3 (da) 2011-03-28
WO2006132310A1 (ja) 2006-12-14
KR20080019054A (ko) 2008-02-29
JP4447640B2 (ja) 2010-04-07
NZ564399A (en) 2010-09-30
US20090098061A1 (en) 2009-04-16
TW200722094A (en) 2007-06-16
EP1905443B1 (en) 2010-12-15
EP1905443A4 (en) 2009-12-16
MY142987A (en) 2011-02-14
JPWO2006132310A1 (ja) 2009-01-08
BRPI0610889A8 (pt) 2017-01-24
AU2006256084A1 (en) 2006-12-14
CN101193645A (zh) 2008-06-04
US20110166089A1 (en) 2011-07-07
US9155751B2 (en) 2015-10-13
KR101004551B1 (ko) 2011-01-03
CA2611441C (en) 2012-03-06
RU2007149561A (ru) 2009-07-20
PL1905443T3 (pl) 2011-05-31
AU2006256084B2 (en) 2010-01-28
RU2395287C2 (ru) 2010-07-27
HK1113746A1 (en) 2008-10-17
PT1905443E (pt) 2011-03-07
SI1905443T1 (sl) 2011-04-29
CN101193645B (zh) 2010-12-08
DE602006018936D1 (de) 2011-01-27
NO20080106L (no) 2008-01-07
CA2611441A1 (en) 2006-12-14
BRPI0610889A2 (pt) 2010-08-03

Similar Documents

Publication Publication Date Title
CY1111453T1 (el) Υγρο που περιλαμβανει τρεαλοζη για χρηση στην προληψη συμφυσης ιστου
CY1121125T1 (el) Συνθεσεις για τη θεραπευτικη αντιμετωπιση του πονου και/ή της φλεγμονης
CY1119547T1 (el) Ενωσεις, συνθεσεις και μεθοδοι χρησιμες για κινητοποιηση χοληστερολης
BR112015013711B8 (pt) membranas em hidrogel para prevenção de aderência
ATE464002T1 (de) Verlängerungen für chirurgischen retraktor
WO2012122006A3 (en) Surgical ligation clip and applicator device
BR112014012689A2 (pt) montagem e método de uso de um cateter e método para administração de uma composição antimicrobiana
DE602004023605D1 (de) Verbesserter einwegapplikator für topische zusammensetzung
ECSP109960A (es) Gel conteniendo pirfenidona
WO2017035221A3 (en) Medical devices and methods
BR112014016314A8 (pt) cânula com menos ferida
BR112018003870A2 (pt) construções cirúrgicas tubulares incluindo material auxiliar
GT200600366A (es) Compuestos de imidazol sustituido como inhibidores de ksp
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
CA2984149A1 (en) Medical liquid dispensing applicators and methods of manufacture
FR2978665B1 (fr) Composition antiseptique
AR101581A1 (es) Composición de colutorio
BR112015032284A2 (pt) dispositivo médico compreendendo colágeno-vi
CY1116274T1 (el) Παραγωγο τριαζολιου για χρηση στη θεραπεια του νευροπαθητικου πονου και της ινομυαλγιας
BR112015022111A2 (pt) sistemas a laser para perfuração de orifícios em dispositivos médicos
BR112017010935A2 (pt) dispositivo para penetração de uma barreira biológica, método para prover um tratamento cosmético e método para entregar um agente através de uma barreira biológica
EA201891552A1 (ru) Морфо-анатомическое гибкое полотно
TH86948B (th) สารละลายสำหรับการป้องกันการยึดติดของเนื้อเยื่อและวิธีการสำหรับการป้องกันการยึดติดของเนื้อเยื่อ
TH86948A (th) สารละลายสำหรับการป้องกันการยึดติดของเนื้อเยื่อและวิธีการสำหรับการป้องกันการยึดติดของเนื้อเยื่อ
IT201700116889A1 (it) Dispositivo nebulizzatore di un fluido per la cura e/o la protezione della pelle, in particolare di principi attivi.